Advertisement
Singapore markets closed
  • Straits Times Index

    3,292.93
    -3.96 (-0.12%)
     
  • Nikkei

    38,236.07
    -37.98 (-0.10%)
     
  • Hang Seng

    18,475.92
    +268.79 (+1.48%)
     
  • FTSE 100

    8,213.49
    +41.34 (+0.51%)
     
  • Bitcoin USD

    62,948.83
    +4,149.27 (+7.06%)
     
  • CMC Crypto 200

    1,363.78
    +86.80 (+6.81%)
     
  • S&P 500

    5,127.79
    +63.59 (+1.26%)
     
  • Dow

    38,675.68
    +450.02 (+1.18%)
     
  • Nasdaq

    16,156.33
    +315.37 (+1.99%)
     
  • Gold

    2,311.10
    +1.50 (+0.06%)
     
  • Crude Oil

    77.96
    -0.99 (-1.25%)
     
  • 10-Yr Bond

    4.5000
    -0.0710 (-1.55%)
     
  • FTSE Bursa Malaysia

    1,589.59
    +9.29 (+0.59%)
     
  • Jakarta Composite Index

    7,134.72
    +17.30 (+0.24%)
     
  • PSE Index

    6,615.55
    -31.00 (-0.47%)
     

ANI: Q4 Earnings Snapshot

BAUDETTE, Minn. (AP) _ ANI Pharmaceuticals Inc. (ANIP) on Tuesday reported a loss of $3.6 million in its fourth quarter.

On a per-share basis, the Baudette, Minnesota-based company said it had a loss of 30 cents. Earnings, adjusted for one-time gains and costs, were 80 cents per share.

The drugmaker posted revenue of $57.3 million in the period.

For the year, the company reported a loss of $22.5 million, or $1.88 per share, swinging to a loss in the period. Revenue was reported as $208.5 million.

ANI shares have climbed 4.5% since the beginning of the year. The stock has fallen 29% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ANIP at https://www.zacks.com/ap/ANIP